Stefania Raimondo

Dr. Stefania Raimondo

University of Turin
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009
Verified
Book Chapter
Closed access
Stefano GeunaStefano Geuna
Stefano Geuna
Stefania RaimondoStefania Raimondo
Stefania Raimondo
GRGiulia Ronchi
Giulia Ronchi
FSFederica Di Scipio
Federica Di Scipio
PTPierluigi Tos
Pierluigi Tos
Michele FornaroMichele Fornaro
Michele Fornaro

6 February 2006 in Basic Research in Cardiology
Verified
Journal Article
Closed access
PDF file
CPC. Penna
C. Penna
RRRaffaella Rastaldo
Raffaella Rastaldo
Daniele MancardiDaniele Mancardi
Daniele Mancardi
Stefania RaimondoStefania Raimondo
Stefania Raimondo
SCS. Cappello
S. Cappello
Pasquale PagliaroPasquale Pagliaro
Pasquale Pagliaro

1 December 2013 in Biomaterials
Verified
Journal Article
Open access
KHKirsten Haastert-Talini
Kirsten Haastert-Talini
Stefano GeunaStefano Geuna
Stefano Geuna
LDLars B. Dahlin
Lars B. Dahlin
CMCora Meyer
Cora Meyer
LSLena Stenberg
Lena Stenberg
CGClaudia Grothe
Claudia Grothe
Biosynthetic nerve grafts are desired as alternative to autologous nerve grafts in peripheral nerve reconstruction. Artificial nerve conduits still have their limitations and are not widely accepted in the clinical setting. Here we report an analysis of fine-tuned chitosan tubes used to reconstruct 10 mm nerve defects in the adult rat. The chitosan tubes displayed low, medium and high degrees of acetylation (DAI: ≈ 2%, DA: ≈ 5%, DAIII: ≈ 20%) and therefore different degradability and microenvironments for the regenerating nerve tissue. Short and long term investigations were performed demonstrating that the chitosan tubes allowed functional and morphological nerve regeneration similar to autologous nerve grafts. Irrespective of the DA growth factor regulation demonstrated to be the same as in controls. Analyses of stereological parameters as well as the immunological tissue response at the implantation site and in the regenerated nerves, revealed that DAI and DAIII chitosan tubes displayed some limitations in the support of axonal regeneration and a high speed of degradation accompanied with low mechanical stability, respectively. The chitosan tubes combine several pre-requisites for a clinical acceptance and DAII chitosan tubes have to be judged as the most supportive for peripheral nerve regeneration.

4 March 2008 in Microscopy Research and Technique
Verified
Journal Article
Closed access
PDF file
FSFederica Di Scipio
Federica Di Scipio
Stefania RaimondoStefania Raimondo
Stefania Raimondo
PTPierluigi Tos
Pierluigi Tos
Stefano GeunaStefano Geuna
Stefano Geuna

Verified
Journal Article
Open access
PDF file
ALAndrea Lavorato
Andrea Lavorato
Stefania RaimondoStefania Raimondo
Stefania Raimondo
MBMarina Boido
Marina Boido
Salvatore PetroneSalvatore Petrone
Salvatore Petrone
GDGiorgia Durante
Giorgia Durante
DGDiego Garbossa
Diego Garbossa
Traumatic peripheral nerve lesions affect hundreds of thousands of patients every year; their consequences are life-altering and often devastating and cause alterations in movement and sensitivity. Spontaneous peripheral nerve recovery is often inadequate. In this context, nowadays, cell therapy represents one of the most innovative approaches in the field of nerve repair therapies. The purpose of this systematic review is to discuss the features of different types of mesenchymal stem cells (MSCs) relevant for peripheral nerve regeneration after nerve injury. The published literature was reviewed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A combination of the keywords “nerve regeneration”, “stem cells”, “peripheral nerve injury”, “rat”, and “human” were used. Additionally, a “MeSH” research was performed in PubMed using the terms “stem cells” and “nerve regeneration”. The characteristics of the most widely used MSCs, their paracrine potential, targeted stimulation, and differentiation potentials into Schwann-like and neuronal-like cells are described in this paper. Considering their ability to support and stimulate axonal growth, their remarkable paracrine activity, their presumed differentiation potential, their extremely low immunogenicity, and their high survival rate after transplantation, ADSCs appear to be the most suitable and promising MSCs for the recovery of peripheral nerve lesion. Clinical considerations are finally reported.

16 October 2020 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
BFBenedetta E. Fornasari
Benedetta E. Fornasari
GCGiacomo Carta
Giacomo Carta
GGGiovanna Gambarotta
Giovanna Gambarotta
Stefania RaimondoStefania Raimondo
Stefania Raimondo
Peripheral nerve injury treatment is a relevant problem because of nerve lesion high incidence and because of unsatisfactory regeneration after severe injuries, thus resulting in a reduced patient’s life quality. To repair severe nerve injuries characterized by substance loss and to improve the regeneration outcome at both motor and sensory level, different strategies have been investigated. Although autograft remains the gold standard technique, a growing number of research articles concerning nerve conduit use has been reported in the last years. Nerve conduits aim to overcome autograft disadvantages, but they must satisfy some requirements to be suitable for nerve repair. A universal ideal conduit does not exist, since conduit properties have to be evaluated case by case; nevertheless, because of their high biocompatibility and biodegradability, natural-based biomaterials have great potentiality to be used to produce nerve guides. Although they share many characteristics with synthetic biomaterials, natural-based biomaterials should also be preferable because of their extraction sources; indeed, these biomaterials are obtained from different renewable sources or food waste, thus reducing environmental impact and enhancing sustainability in comparison to synthetic ones. This review reports the strengths and weaknesses of natural-based biomaterials used for manufacturing peripheral nerve conduits, analyzing the interactions between natural-based biomaterials and biological environment. Particular attention was paid to the description of the preclinical outcome of nerve regeneration in injury repaired with the different natural-based conduits.